CEO and CFO
+46 (0) 73 042 99 97
Employed since 2021.
• Born: 1968
• Education: BSc Business Administration
• Experience: Has held leading positions such as a. CEO of Occlutech International AB, CFO of CellaVision AB (publ), CFO of Enzymatica AB (publ) and board member of Scandinavian Chemotech (publ) and Exini Diagnostics AB (publ). Serves on the board of Invent Medic Sweden AB (publ) and Inuheat Group AB (publ) as well as some unlisted companies. Wennerholm is the owner of Nordic Infrastructure AB.
• Holdings: 370 000 shares (via companies)
Marketing & Sales Director
+46 (0) 70 560 10 95
Consultant in the company.
• Born: 1971
• Education: BSc in Business Administration
• Experience: More than 20 years of experience in the Life Science sector, AstraZeneca, Alcon and
Allergan in various positions in marketing and sales, including sales rep., Product Manager, Sales Manager, Marketing Manager and Business Unit Manager. Board assignments in some unlisted companies. Dybner is a partner in Dybner Holding AB
• Holding: 348 750 shares
QA / RA Director
+46 (0) 70 822 00 93
Employed since 2019.
• Born: 1968
• Education: Chemical engineer and university studies in analytical chemistry, University of Gothenburg
• Experience: Over 25 years of experience from the Medical Device industry in the areas of R&D, Quality, Project Management, Supply chain and also has 4 patents in urology products. Worked with medical technology products class I to III combination products at Astra Tech, Fresenius Hemocare, BoneSupport and Enzymatica
• Holding: 22 500 shares